Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kriti Negi"'
Autor:
Isha Pahuja, Antara Ghoshal, Ahmed Abdallah Okieh, Akanksha Verma, Kriti Negi, Meetu Agarwal, Nidhi Subhash Chandra, Saurabh Kumar Sharma, Ashima Bhaskar, Ved Prakash Dwivedi
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 7 (2024)
ABSTRACT The host immune responses play a pivotal role in the establishment of long-term memory responses, which effectively aids in infection clearance. However, the prevailing anti-tuberculosis therapy, while aiming to combat tuberculosis (TB), als
Externí odkaz:
https://doaj.org/article/6099b1271ad74eb9bfa8b12dd780f110
Autor:
Ashima Bhaskar, Isha Pahuja, Kriti Negi, Akanksha Verma, Antara Ghoshal, Babu Mathew, Gaurav Tripathi, Jaswinder Singh Maras, Shivam Chaturvedi, Ved Prakash Dwivedi
Publikováno v:
iScience, Vol 26, Iss 5, Pp 106644- (2023)
Summary: Bacille Calmette-Guerin (BCG) generates limited long-lasting adaptive memory responses leading to short-lived protection against adult pulmonary tuberculosis (TB). Here, we show that host sirtuin 2 (SIRT2) inhibition by AGK2 significantly en
Externí odkaz:
https://doaj.org/article/b1a568ab7b094d5db897ff8de9f22986
Autor:
Isha Pahuja, Kriti Negi, Anjna Kumari, Meetu Agarwal, Suparba Mukhopadhyay, Babu Mathew, Shivam Chaturvedi, Jaswinder Singh Maras, Ashima Bhaskar, Ved Prakash Dwivedi
Publikováno v:
PLoS Pathogens, Vol 19, Iss 3, p e1011165 (2023)
Stimulation of naïve T cells during primary infection or vaccination drives the differentiation and expansion of effector and memory T cells that mediate immediate and long-term protection. Despite self-reliant rescue from infection, BCG vaccination
Externí odkaz:
https://doaj.org/article/967590c0dc944bd3aa614868c04c107d
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The pursuit to improve the TB control program comprising one approved vaccine, M. bovis Bacille Calmette-Guerin (BCG) has directed researchers to explore progressive approaches to halt the eternal TB pandemic. Mycobacterium tuberculosis (M.tb) was fi
Externí odkaz:
https://doaj.org/article/df5246c0de8b40ea8513b20a7c46835c
Autor:
Dhiraj Kumar Singh, Sultan Tousif, Ashima Bhaskar, Annu Devi, Kriti Negi, Barnani Moitra, Anand Ranganathan, Ved Prakash Dwivedi, Gobardhan Das
Publikováno v:
PLoS Pathogens, Vol 17, Iss 8, p e1009805 (2021)
Tuberculosis (TB) remains a major health problem throughout the world with one third of the population latently infected and ~1.74 million deaths annually. Current therapy consists of multiple antibiotics and a lengthy treatment regimen, which is ass
Externí odkaz:
https://doaj.org/article/93fb6bb20ab94443ba71835315feeff6
Autor:
Anjna Kumari, Isha Pahuja, Kriti Negi, Antara Ghoshal, Suparba Mukopadhyay, Meetu Agarwal, Babu Mathew, Jaswinder Singh Maras, Shivam Chaturvedi, Ashima Bhaskar, Ved Prakash Dwivedi
Publikováno v:
Microbiology Spectrum. 11
Despite being extensive, conventional antituberculosis therapy (ATT) is barely proficient in providing sterile immunity to tuberculosis (TB). Failure to constrain the escalating global TB burden due to the emergence of drug-resistant bacterial strain
Autor:
Kriti Negi, Meetu Agarwal, Isha Pahuja, Bhavya Bhardwaj, Mansi Rawat, Ashima Bhaskar, Ved Prakash Dwivedi
Publikováno v:
Oxford Open Immunology. 4
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes lethal coronavirus disease (COVID-19). SARS-CoV-2 has been the chief source of threat to public health and safety from 2019 to the present. SARS-CoV-2 caused a sudden and s
Autor:
Annu Devi, Kriti Negi, Gobardhan Das, Sultan Tousif, Ashima Bhaskar, Anand Ranganathan, Dhiraj Kumar Singh, Barnani Moitra, Ved Prakash Dwivedi
Publikováno v:
PLoS Pathogens, Vol 17, Iss 8, p e1009805 (2021)
PLoS Pathogens
PLoS Pathogens
Tuberculosis (TB) remains a major health problem throughout the world with one third of the population latently infected and ~1.74 million deaths annually. Current therapy consists of multiple antibiotics and a lengthy treatment regimen, which is ass